Ann: Mayne Pharma CEO announces plan to retire, page-25

Selling Metrics contract services together with manufacturing site we now have or will have a company much much smaller almost completely reliant on the success of Nexstellis ( and a few other products) given what we paid both cash +a big slice of the company . Now we're almost debt free what are we left with now reliable proven high growth earning assets sold used to repay debt . Massive share holder money / borrowings used to grow Mayne now massively downsized so what's Mayne actually achieved after all these years , very little it seems apart from building debt buying hugely costly products based mostly on potential future earning , our proven solid assets used to repay debt . Our now sold Carolina manufacturing plant in the US combined with Metrics contract services was a big massively expensive undertaking , going offshore building establishing etc now sold to repay debt , so much for companies growth early share holders simply used to support that growth . . Richards probably pushed been on borrowed time too long ever since Teva .